天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Home Cart 0 Sign in  

[ CAS No. 17920-35-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 17920-35-3
Chemical Structure| 17920-35-3
Structure of 17920-35-3 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 17920-35-3 ]

Related Doc. of [ 17920-35-3 ]

Alternatived Products of [ 17920-35-3 ]
Product Citations

Product Citations

Hill, Jarvis ; Givhan, R Houston ; Yi, Bin , et al. DOI: PubMed ID:

Abstract: The permeability glycoprotein, encoded by the ABCB1 gene, is widely implicated in multidrug resistance (MDR), as it has been shown to reduce the intracellular concentration of most small molecule therapeutics, including the majority of the breakpoint cluster region Abelson proto-oncogene 1 (BCR-ABL1) kinase inhibitors used in the treatment of Philadelphia chromosome positive (Ph+) leukemias. With this in mind, we describe an integrated theoretical and experimental approach to shed light on substituent effects in the pendant anilino moiety of 4-anilinoquinazolines and 4-anilinoquinoline-3-carbonitrile-based kinase inhibitors and their influence on P-gp-mediated efflux. This analysis culminated in the identification of a hydroxylamine-bearing, dual cSRC/BCR-ABL1 kinase inhibitor 16a that exhibits a marked reduction in P-gp-mediated efflux ratio and potent activity in a Ph+ patient derived cell line (K562) and an MDR-Ph+ patient-derived cell line (K562/Dox) overexpressing . Overall, we demonstrate that the P-gp-mediated efflux ratio can be minimized by computationally driven optimization of the molecular dipole and/or cpKa without recourse to intramolecular hydrogen bonds.

Purchased from AmBeed:

Product Details of [ 17920-35-3 ]

CAS No. :17920-35-3 MDL No. :MFCD04972542
Formula : C6H8N2O Boiling Point : No data available
Linear Structure Formula :- InChI Key :DEUALFRBMNMGDS-UHFFFAOYSA-N
M.W : 124.14 Pubchem ID :580053
Synonyms :

Calculated chemistry of [ 17920-35-3 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.17
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 35.13
TPSA : 48.14 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.89 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.5
Log Po/w (XLOGP3) : 1.65
Log Po/w (WLOGP) : 0.68
Log Po/w (MLOGP) : 0.33
Log Po/w (SILICOS-IT) : 0.64
Consensus Log Po/w : 0.96

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.08
Solubility : 1.04 mg/ml ; 0.00838 mol/l
Class : Soluble
Log S (Ali) : -2.27
Solubility : 0.66 mg/ml ; 0.00532 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.75
Solubility : 2.21 mg/ml ; 0.0178 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.76

Safety of [ 17920-35-3 ]

Signal Word:Warning Class:
Precautionary Statements:P305+P351+P338 UN#:
Hazard Statements:H302-H319 Packing Group:
GHS Pictogram:
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 17920-35-3 ]

Ethers

Chemical Structure| 1131007-43-6

[ 1131007-43-6 ]

6-(Difluoromethoxy)pyridin-2-amine

Similarity: 0.84

Chemical Structure| 262295-96-5

[ 262295-96-5 ]

(6-Methoxypyridin-3-yl)methanamine

Similarity: 0.81

Chemical Structure| 169045-12-9

[ 169045-12-9 ]

(6-Methoxypyridin-3-yl)methanamine dihydrochloride

Similarity: 0.80

Chemical Structure| 1211533-83-3

[ 1211533-83-3 ]

5-Bromo-6-methoxypyridin-2-amine

Similarity: 0.79

Chemical Structure| 127980-46-5

[ 127980-46-5 ]

5,6-Dimethoxypyridin-2-amine

Similarity: 0.77

Amines

Chemical Structure| 1131007-43-6

[ 1131007-43-6 ]

6-(Difluoromethoxy)pyridin-2-amine

Similarity: 0.84

Chemical Structure| 262295-96-5

[ 262295-96-5 ]

(6-Methoxypyridin-3-yl)methanamine

Similarity: 0.81

Chemical Structure| 169045-12-9

[ 169045-12-9 ]

(6-Methoxypyridin-3-yl)methanamine dihydrochloride

Similarity: 0.80

Chemical Structure| 1211533-83-3

[ 1211533-83-3 ]

5-Bromo-6-methoxypyridin-2-amine

Similarity: 0.79

Chemical Structure| 127980-46-5

[ 127980-46-5 ]

5,6-Dimethoxypyridin-2-amine

Similarity: 0.77

Related Parent Nucleus of
[ 17920-35-3 ]

Pyridines

Chemical Structure| 1131007-43-6

[ 1131007-43-6 ]

6-(Difluoromethoxy)pyridin-2-amine

Similarity: 0.84

Chemical Structure| 262295-96-5

[ 262295-96-5 ]

(6-Methoxypyridin-3-yl)methanamine

Similarity: 0.81

Chemical Structure| 169045-12-9

[ 169045-12-9 ]

(6-Methoxypyridin-3-yl)methanamine dihydrochloride

Similarity: 0.80

Chemical Structure| 1211533-83-3

[ 1211533-83-3 ]

5-Bromo-6-methoxypyridin-2-amine

Similarity: 0.79

Chemical Structure| 127980-46-5

[ 127980-46-5 ]

5,6-Dimethoxypyridin-2-amine

Similarity: 0.77

; ;